LON:LIDLiDCO Group Share Price, Forecast & News

GBX 7

+0.25 (+3.70 %)

(As of 06/5/2020 05:52 AM ET)

Add

Compare

Today's Range

6.67

Now: GBX 7▼

50-Day Range

6.75

MA: GBX 7.77▼

52-Week Range

3.50

Now: GBX 7▼

10.90

Volume84,253 shs

Average Volume183,119 shs

Market Capitalization£17.09 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company provides a range of closed and open pressure monitoring sets for use in the ICU, operating department, and Cath labs; and Stimpod NMS 450X, a quantitative neuromuscular blocking agent monitor. It also offers LiDCOunity, a hemodynamic monitor to support clinical decision making; and LiDCOrapid, a cardiac output monitor that analyses the blood pressure waveform to provide information in surgical and critically ill patients to help with fluid and drug management. In addition, the company offers LiDCOplus, a hemodynamic monitor, which provides assessment of the hemodynamic status of critical care and surgery patients; LiDCOview that offers clinical researchers and users with beat-to-beat hemodynamic data; and accessories, including blood pressure modules. LiDCO Group Plc was founded in 1991 and is headquartered in London, the United Kingdom.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for LiDCO Group.

1.9 Community Rank

Outperform Votes
LiDCO Group has received 167 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
LiDCO Group has received 268 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
LiDCO Group has received 61.61% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about LiDCO Group and other stocks. Vote “Outperform” if you believe LID will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LID will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
LiDCO Group does not currently pay a dividend.
Dividend Growth
LiDCO Group does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LiDCO Group insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Earnings Growth
Earnings for LiDCO Group are expected to grow in the coming year, from GBX (0.45) to GBX 0 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of LiDCO Group is -17.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of LiDCO Group is -17.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
LiDCO Group has a P/B Ratio of 3.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.51 out of 5 stars

Industry, Sector and Symbol

Stock Exchange LON

Industry Medical Appliances & Equipment

Sub-IndustryN/A

SectorMedical

Current SymbolLON:LID

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.lidco.com

Phone+44-20-77491500

Debt

Debt-to-Equity Ratio4.21

Current Ratio1.82

Quick Ratio1.18

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales£7.55 million

Price / Sales2.26

Cash FlowGBX 0.56 per share

Price / Cash Flow12.50

Book ValueGBX 2.30 per share

Price / Book3.04

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees48

Outstanding Shares244,175,008

Market Cap£17.09 million

Next Earnings DateN/A

OptionableNot Optionable

Receive LID News and Ratings via Email

Sign-up to receive the latest news and ratings for LID and its competitors with MarketBeat's FREE daily newsletter.

LiDCO Group (LON:LID) Frequently Asked Questions

How has LiDCO Group's stock been impacted by COVID-19 (Coronavirus)?

LiDCO Group's stock was trading at GBX 5.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LID stock has increased by 21.7% and is now trading at GBX 7. View which stocks have been most impacted by Coronavirus.

How were LiDCO Group's earnings last quarter?

LiDCO Group plc (LON:LID) posted its earnings results on Tuesday, April, 21st. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by $0.02. View LiDCO Group's earnings history.

Has LiDCO Group been receiving favorable news coverage?

Media stories about LID stock have been trending negative recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. LiDCO Group earned a media sentiment score of -2.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutLiDCO Group.

Who are some of LiDCO Group's key competitors?

Some companies that are related to LiDCO Group include Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), Deltex Medical Group (DEMG), InspireMD (NSPR), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS). View all competitors.

What other stocks do shareholders of LiDCO Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LiDCO Group investors own include African Potash (AFPO), Satellite Solutions Worldwide (SAT), El Pollo LoCo (LOCO), ANGLE (AGL), AptarGroup (ATR), Broadcom (AVGO), Best of the Best (BOTB), Biopharma Credit (BPCR), Destiny Pharma (DEST) and DX (Group) (DX).

Who are LiDCO Group's key executives?

LiDCO Group's management team includes the following people:

Mr. Matthew G. Sassone, CEO & Director
Dr. Terence K. O'Brien, Co-Founder & Member of Clinical Advisory Board (Age 64)
Dr. David M. Band, Co-Founder
Mr. Tim R. Hall, CFO, Company Sec. & Director (Age 56)
Mr. Shane Doorish, Head of North America

What is LiDCO Group's stock symbol?

LiDCO Group trades on the London Stock Exchange (LON) under the ticker symbol "LID."

How do I buy shares of LiDCO Group?

Shares of LID and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is LiDCO Group's stock price today?

One share of LID stock can currently be purchased for approximately GBX 7.

How big of a company is LiDCO Group?

LiDCO Group has a market capitalization of £17.09 million and generates £7.55 million in revenue each year. LiDCO Group employs 48 workers across the globe.

What is LiDCO Group's official website?

The official website for LiDCO Group is www.lidco.com.

How can I contact LiDCO Group?

LiDCO Group's mailing address is 16 Orsman Road, LONDON, N1 5QJ, United Kingdom. The company can be reached via phone at +44-20-77491500.

This page was last updated on 6/5/2020 by MarketBeat.com Staff